Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

ClinicalTrials.gov ID: NCT06625060

Public ClinicalTrials.gov record NCT06625060. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 12:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose Escalation and Dose Finding Phase II Study to Evaluate the Safety and Efficacy of IPN10200 in the Prevention of Episodic or Chronic Migraine in Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head. It is often accompanied by feeling or being sick and a sensitivity to bright lights and sound. Migraines are caused by a series of events when the brain gets stimulated or activated, which causes the release of chemicals that cause pain. Corabotase (also known as IPN10200) is a medication that stops the release of these chemical messengers. Participants with episodic migraine (EM) or chronic migraine (CM) will be included in both Step 1 and Step 2. "Headache days" are when participants experience headaches that meet the criteria for a migraine or a headache without the additional migraine-specific symptoms. "Migraine days" occur when the headache displays clear migraine characteristics. This study aims to determine: * The safety and efficacy of injecting Corabotase directly into the muscles of the head and neck to prevent EM and CM, * The right amount (dose) of Corabotase to inject at each point, * The total amount (dose) of Corabotase that provides the best balance between safety and efficacy preventing migraines. Participants will need to complete a daily electronic migraine Diary (eDiary) and questionnaires throughout the study. The total study duration for a participant will be up to 44 weeks.

Study identification

NCT ID
NCT06625060
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ipsen
Industry
Enrollment
670 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 10, 2024 (Actual)
Primary completion
Oct 31, 2027 (Estimated)
Completion
Oct 31, 2027 (Estimated)
Last update posted
Sep 8, 2026

2024 – 2027

United States locations

U.S. sites
68
U.S. states
22
U.S. cities
54
Facility City State ZIP Site status
Central Research Associates Birmingham Alabama 35205 —
Rehabilitation & Neurological Services, LLC Huntsville Alabama 35801 —
MD First Research - Chandler - Neurology Chandler Arizona 85224 —
MD First Research - Chandler Chandler Arizona 85286 —
Axiom Research, LLC Apple Valley California 92308 —
Profound Research. LLC - NCSC Carlsbad California 92011 —
M3Wake -PRI Encino Encino California 91316 —
WR-PRI Encino Encino California 91316 —
Neuro-Pain Medical Center Fresno California 93710 —
Fullerton Neurological Center - Neurology Fullerton California 92832 —
Neurology Center of North Orange County Fullerton California 92832 —
Kaizen Brain Center La Jolla California 92037 —
Pharmacology Research Institute (PRI) Los Alamitos California 90720 —
Pharmacology Research Institute (PRI) - Los Alamitos/Long Beach Newport Beach California 92660 —
Profound Research, LLC Pasadena California 91105 —
Acclaim Clinical Research - Internal Medicine San Diego California 92101 —
Clinical Trials Management LLC Thousand Oaks California 91360 —
Alliance Clinical West Hills (Focus Clinical Research) West Hills California 91307 —
Advanced Neuroscience Research Center, LLC Fort Collins Colorado 80501 —
Advanced Neuroscience Research Center, LLC - Neurology Fort Collins Colorado 80524 —
New England Institute for Neurology and Headache (NEINH)/Medical Practice Stamford Connecticut 06901 —
Neurology Offices Boca Raton Florida 33432 —
AGA Clinical Trials Hialeah Florida 33012 —
M3 Wake Research/MSRA, LLC Lake City Florida 32055 —
M3 Wake Research/MSRA,LLC Lake City Florida 32055 —
Renstar Medical Research Ocala Florida 34471 —
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801 —
Emerald Coast Center For Neurological Disorders Pensacola Florida 32502 —
Conquest Research Winter Park Florida 32789 —
NeuroTrials Research, Inc. Atlanta Georgia 30309 —
Crescent City Headache and Neurology Center, LLC Chalmette Louisiana 70043 —
Ochsner Health Center - Covington Covington Louisiana 70433 —
DelRicht Research New Orleans Louisiana 70112 —
DelRicht Research at Touro Medical Center New Orleans Louisiana 70115 —
LSU Healthcare Network Orthopedic & Sports Medicine New Orleans Louisiana 70115 —
MedStar Neurosciences and Rehabilitation Research Network Baltimore Maryland 21218 —
MedStar Neurosciences and Rehabilitation Baltimore Maryland 21218 —
MedStar Franklin Square Hospital Center Baltimore Maryland 21237 —
Medstar Franklin Square Medical Center Baltimore Maryland 21237 —
Neurology Center of NE,PC - Neurology Foxborough Massachusetts 02035 —
MedVadis Research Waltham Massachusetts 02451 —
Mass Institute of Clinical Research Westborough Massachusetts 01581 —
Michigan Head Pain & Neurological Institute - Neurology/Pain Ann Arbor Michigan 48104 —
Michigan Head Pain & Neurological Institute Ann Arbor Michigan 48104 —
Michigan Center of Medical Research Grand Blanc Michigan 48439 —
Minneapolis Clinic-Neurology Burnsville Minnesota 55306 —
Papillion Research Center/Avacare Papillion Nebraska 68046 —
Alliance Clinical Las Vegas (Excel Clinical Research) - Internal Medicine Las Vegas Nevada 89101 —
Integrative Clinical Trials, LLC Brooklyn New York 11229 —
Montefiore Medical Center: Headache Center The Bronx New York 10461 —
Upstate Clinical Research Associates - Research Center Williamsville New York 14221 —
Upstate Clinical Research Associates Williamsville New York 14221 —
UC Gardner Neuroscience Institute Cincinnati Ohio 45219 —
Neurology Diagnostics, Inc. Dayton Ohio 45459 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
Preferred Primary Care Physicians - Curry Hollow Pittsburgh Pennsylvania 15236 —
Clinical Neuroscience Solutions, Inc - Memphis Memphis Tennessee 38119 —
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119 —
Zenos Clinical Research - Internal Medicine Dallas Texas 75201 —
Lone Star Neurology Frisco Texas 75034 —
Elevate Clinical Research - Houston Houston Texas 77002 —
Javara Inc. - Houston, TX Houston Texas 77002 —
Javara Inc. - New Caney, TX New Caney Texas 77357 —
J. Lewis Research-Site Number:8400053 Salt Lake City Utah 84101 —
ChronicleBio West Valley City Utah 84119 —
Puget Sound Neurology - Neurology Tacoma Washington 98409 —
Marshall Health Clinical Research Center Huntington West Virginia 25701 —
Frontier Clinical Research, LLC - Kingwood Kingwood West Virginia 26537 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06625060, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 8, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06625060 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →